company,drug,streak,start,end,reasons,color,,,,,,,,,,,,,,
Graceway,edetate,1,6/6/09,7/5/09,Demand increase,orange,Increase in demand,,,,,,,,,,,,,
Carlsbad,acyclovir,1,4/8/10,7/3/10,Manufacturing delays; Demand increase,blue,Manufacturing Delays---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ----Pending site transfer---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand;Manufacturing Delays---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ----Pending site transfer---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand;Manufacturing Delays---- ---- ----Increased Demand---- ---- ---- ---- ---- ----Pending site transfer---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand,,,,,,,,,,,,,
GlaxoSmithKline,acyclovir,1,1/17/10,7/3/10,Manufacturing delays; Demand increase,blue,Manufacturing Delays---- ---- ----Increased Demand;Manufacturing Delays---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ----Pending site transfer---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand;Manufacturing Delays---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ----Pending site transfer---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand;Manufacturing Delays---- ---- ----Increased Demand---- ---- ---- ---- ---- ----Pending site transfer---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand,,,,,,,,,,,,,
Mylan,acyclovir,1,1/25/10,7/3/10,Manufacturing delays; Demand increase,blue,Manufacturing Delays---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ----Pending site transfer---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand;Manufacturing Delays---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ----Pending site transfer---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand;Manufacturing Delays---- ---- ----Increased Demand---- ---- ---- ---- ---- ----Pending site transfer---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand,,,,,,,,,,,,,
Teva,acyclovir,1,1/17/10,7/3/10,Manufacturing delays; Demand increase,blue,Manufacturing Delays---- ---- ----Increased Demand;Manufacturing Delays---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ---- ----Pending site transfer;Manufacturing Delays---- ---- ---- ---- ----Increased Demand---- ---- ---- ---- ----Pending site transfer---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand;Manufacturing Delays---- ---- ----Increased Demand---- ---- ---- ---- ---- ---- ----Pending site transfer---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand;Manufacturing Delays---- ---- ----Increased Demand---- ---- ---- ---- ---- ----Pending site transfer---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increased Demand,,,,,,,,,,,,,
Bedford,adriamycin,1,10/19/10,11/12/10,Demand increase,orange,Increased demand-- ,,,,,,,,,,,,,
Bedford,amikacin,1,7/9/10,10/9/10,Manufacturing delays,green,Manufacturing delays reported by both manufacturers.--;Manufacturing delays reported by both manufacturers.-- ,,,,,,,,,,,,,
Bedford,amikacin,2,12/18/10,4/22/11,Manufacturing delays,blue,Manufacturing delays----Manufacturing delays-- ;Manufacturing delays----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays;Manufacturing delays--             --             --             --             --             --             --             --             --             --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
Teva,amikacin,1,7/9/10,10/9/10,Manufacturing delays,blue,Manufacturing delays reported by both manufacturers.--;Manufacturing delays reported by both manufacturers.-- ,,,,,,,,,,,,,
Teva,amikacin,2,12/18/10,4/22/11,Manufacturing delays,blue,Manufacturing delays----Manufacturing delays-- ;Manufacturing delays----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays;Manufacturing delays--             --             --             --             --             --             --             --             --             --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
BBraun,amino,1,10/19/10,4/22/11,Demand increase,orange,Commodity shortage--Increase in demand--Increase in demand-- ;Commodity shortage----            ----            ----            ----            ----            ----            Increase in demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand;Commodity shortage--             --             --             --             --             --             Increase in demand--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Increase in demand,,,,,,,,,,,,,
Baxter,amino,1,10/19/10,4/22/11,Demand increase,orange,Commodity shortage--Increase in demand--Increase in demand-- ;Commodity shortage----            ----            ----            ----            ----            ----            Increase in demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand;Commodity shortage--             --             --             --             --             --             Increase in demand--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Increase in demand,,,,,,,,,,,,,
Hospira,amino,1,10/19/10,4/22/11,Demand increase,orange,Commodity shortage--Increase in demand--Increase in demand-- ;Commodity shortage----            ----            ----            ----            ----            ----            Increase in demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand;Commodity shortage--             --             --             --             --             --             Increase in demand--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Increase in demand,,,,,,,,,,,,,
Hospira,aminophylline,1,10/9/10,1/26/11,Supply interruption,red,Supplier of one excipient can no longer supply; currently arranging for new supplier.-- ,,,,,,,,,,,,,
Hospira,ammonium,1,2/2/11,4/22/11,Supply interruption,red,Supply interruption-- ;Supply interruption,,,,,,,,,,,,,
Ucyclyd,ammonul,1,6/6/09,4/22/11,X,red,See information in Related Information section.--;See information in Related Information section.-- ;See information in Related Information section.,,,,,,,,,,,,,
Global,amphetamine,1,4/14/11,4/22/11,API limitations,red,API limitations due to DEA quota and uneven product distribution patterns.----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            This product is subject to DEA quota limitations.----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Waiting on additional information.;API limitations due to DEA quota and uneven product distribution patterns.--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             This product is subject to DEA quota limitations.--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Waiting on additional information.,,,,,,,,,,,,,
Shire,amphetamine,1,4/14/11,4/22/11,API limitations,red,API limitations due to DEA quota and uneven product distribution patterns.----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            This product is subject to DEA quota limitations.----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Waiting on additional information.;API limitations due to DEA quota and uneven product distribution patterns.--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             This product is subject to DEA quota limitations.--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Waiting on additional information.,,,,,,,,,,,,,
Teva,amphetamine,1,4/14/11,4/22/11,API limitations,red,API limitations due to DEA quota and uneven product distribution patterns.----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            This product is subject to DEA quota limitations.----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Waiting on additional information.;API limitations due to DEA quota and uneven product distribution patterns.--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             This product is subject to DEA quota limitations.--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Waiting on additional information.,,,,,,,,,,,,,
Hospira,aquasol,1,12/9/10,4/22/11,Site change,red,Change in manufacturing sites. ;Change in manufacturing sites.,,,,,,,,,,,,,
Pfizer,arginine,1,11/12/10,4/22/11,Manufacturing delays,red,Manufacturing delays,,,,,,,,,,,,,
Bedford,atracurium,1,4/30/10,12/9/10,Manufacturing delays,red,Manufacturing delays,,,,,,,,,,,,,
BristolMyersSquibb,avalide,1,1/6/11,4/22/11,Manufacturing delays,red,Manufacturing delays,,,,,,,,,,,,,
BMS,azactam,1,3/26/10,5/15/10,Manufacturing delays,red,Manufacturing delays,,,,,,,,,,,,,
BMS,azactam,2,5/27/10,6/25/10,Manufacturing delays,red,Manufacturing delays,,,,,,,,,,,,,
Baxter,azactam,1,6/6/09,6/25/10,Manufacturing delays,purple,Manufacturing delays,,,,,,,,,,,,,
Elan,azactam,1,6/6/09,3/20/10,Manufacturing delays,red,Manufacturing delays,,,,,,,,,,,,,
BristolMyersSquibb,bicnu,1,1/13/11,3/2/11,Manufacturing delays,red,Manufacturing delays at contract manufacturer.,,,,,,,,,,,,,
APP,bleomycin,1,12/18/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand-- ----Manufacturing delays-- ----Manufacturing delays-- --Manufacturing delays-- -- -- ;Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----            ----            ----            ----            ----             --            ----            ----            Manufacturing delays----            ----            ----            ----            ----            ----            ----             --            Manufacturing delays   ;Increased demand--             --             --             --             --             --             --             --             --             --             Manufacturing delays--             --             --             --             --                           --             --             Manufacturing delays--             --             --             --             --             --             --                           Manufacturing delays   ,,,,,,,,,,,,,
Bedford,bleomycin,1,12/18/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand-- ----Manufacturing delays-- ----Manufacturing delays-- --Manufacturing delays-- -- -- ;Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----            ----            ----            ----            ----             --            ----            ----            Manufacturing delays----            ----            ----            ----            ----            ----            ----             --            Manufacturing delays   ;Increased demand--             --             --             --             --             --             --             --             --             --             Manufacturing delays--             --             --             --             --                           --             --             Manufacturing delays--             --             --             --             --             --             --                           Manufacturing delays   ,,,,,,,,,,,,,
Hospira,bleomycin,1,12/18/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand-- ----Manufacturing delays-- ----Manufacturing delays-- --Manufacturing delays-- -- -- ;Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----            ----            ----            ----            ----             --            ----            ----            Manufacturing delays----            ----            ----            ----            ----            ----            ----             --            Manufacturing delays   ;Increased demand--             --             --             --             --             --             --             --             --             --             Manufacturing delays--             --             --             --             --                           --             --             Manufacturing delays--             --             --             --             --             --             --                           Manufacturing delays   ,,,,,,,,,,,,,
Teva,bleomycin,1,12/18/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand-- ----Manufacturing delays-- ----Manufacturing delays-- --Manufacturing delays-- -- -- ;Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----            ----            ----            ----            ----             --            ----            ----            Manufacturing delays----            ----            ----            ----            ----            ----            ----             --            Manufacturing delays   ;Increased demand--             --             --             --             --             --             --             --             --             --             Manufacturing delays--             --             --             --             --                           --             --             Manufacturing delays--             --             --             --             --             --             --                           Manufacturing delays   ,,,,,,,,,,,,,
Baxter,bumetanide,1,10/9/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand--Increased demand-- ;Increased demand--Increased demand-- ----Increased Demand-- ;Increased demand--Increased demand-- --Increased Demand-- ;Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand----             ----            ----            ----            ----            ----            ----            Increased Demand;Increased demand--             --             --             --             --             --             --             --             --             --             --             --             --             --             Increased demand--              --             --             --             --             --             --             Increased Demand,,,,,,,,,,,,,
Bedford,bumetanide,1,10/19/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand--Increased demand-- ----Increased Demand-- ;Increased demand--Increased demand-- --Increased Demand-- ;Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand----             ----            ----            ----            ----            ----            ----            Increased Demand;Increased demand--             --             --             --             --             --             --             --             --             --             --             --             --             --             Increased demand--              --             --             --             --             --             --             Increased Demand,,,,,,,,,,,,,
Hospira,bumetanide,1,10/9/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand--Increased demand-- ;Increased demand--Increased demand-- ----Increased Demand-- ;Increased demand--Increased demand-- --Increased Demand-- ;Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand----             ----            ----            ----            ----            ----            ----            Increased Demand;Increased demand--             --             --             --             --             --             --             --             --             --             --             --             --             --             Increased demand--              --             --             --             --             --             --             Increased Demand,,,,,,,,,,,,,
AmericanRegent,calcium,1,7/16/10,8/15/10,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
AmericanRegent,calcium,2,9/14/10,4/22/11,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Amphastar,calcium,1,4/14/11,4/14/11,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Amphastar(IMS),calcium,1,8/7/10,8/15/10,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Amphastar(IMS),calcium,2,9/14/10,4/7/11,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Amphastar(IMS),calcium,3,4/22/11,4/22/11,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Graceway,calcium,1,7/13/09,10/24/09,Demand increase,orange,Increase in demand,,,,,,,,,,,,,
Hospira,calcium,1,7/16/10,8/15/10,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Hospira,calcium,2,9/14/10,4/22/11,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
APP,calciumg,1,3/11/11,4/22/11,Demand increase,orange,Increase in demand--Increase in demand-- ;Increase in demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand;Increase in demand--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Increase in demand,,,,,,,,,,,,,
Luitpold,calciumg,1,3/11/11,4/22/11,Demand increase,orange,Increase in demand--Increase in demand-- ;Increase in demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand;Increase in demand--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Increase in demand,,,,,,,,,,,,,
Genzyme,cerezyme,1,8/14/09,1/6/11,Manufacturing delays,,Manufacturing delays---- ;Manufacturing delays-- ,,,,,,,,,,,,,
APP,cisplatin,1,6/6/09,6/6/09,Available,red,Available,,,,,,,,,,,,,
APP,cisplatin,2,10/30/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand.--Manufacturing delays--Manufacturing delays-- ;Increased demand.----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----             ;Increased demand.--             --             --             --             --             --             --             --             --             --             Manufacturing delays--             --             --             --             --             --             --             --             --             --             --             Manufacturing delays--              ,,,,,,,,,,,,,
Bedford,cisplatin,1,6/6/09,6/6/09,Available,red,Available,,,,,,,,,,,,,
Bedford,cisplatin,2,8/20/10,4/14/11,Demand increase; Manufacturing delays,orange,Increased demand.--Manufacturing delays--Manufacturing delays--;Increased demand.--Manufacturing delays--Manufacturing delays-- ;Increased demand.----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----             ,,,,,,,,,,,,,
Teva,cisplatin,1,6/6/09,6/6/09,Available,red,Available,,,,,,,,,,,,,
Teva,cisplatin,2,8/20/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand.--Manufacturing delays--Manufacturing delays--;Increased demand.--Manufacturing delays--Manufacturing delays-- ;Increased demand.----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----             ;Increased demand.--             --             --             --             --             --             --             --             --             --             Manufacturing delays--             --             --             --             --             --             --             --             --             --             --             Manufacturing delays--              ,,,,,,,,,,,,,
MedicinesCompany,cleviprex,1,3/26/10,4/22/11,X,red,See Related Information Section,,,,,,,,,,,,,
APP,cytarabine,1,12/18/10,4/22/11,Manufacturing delays,,Manufacturing delays-- ----Manufacturing delays-- ----Raw material issues;Manufacturing delays-- ----Manufacturing delays-- ----API shortage/manufacturing delay-- ;Manufacturing delays----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays--             --            ----            ----            ----            ----            ----            ----            API shortage/manufacturing delay;Manufacturing delays--             --             --             --             --             --             --             --             --             --             --             Manufacturing delays                           --             --             --             --             --             --             --             --             --             --             --             Increased demand,,,,,,,,,,,,,
Bedford,cytarabine,1,12/18/10,4/22/11,Manufacturing delays,red,Manufacturing delays-- ----Manufacturing delays-- ----Raw material issues;Manufacturing delays-- ----Manufacturing delays-- ----API shortage/manufacturing delay-- ;Manufacturing delays----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays--             --            ----            ----            ----            ----            ----            ----            API shortage/manufacturing delay;Manufacturing delays--             --             --             --             --             --             --             --             --             --             --             Manufacturing delays                           --             --             --             --             --             --             --             --             --             --             --             Increased demand,,,,,,,,,,,,,
Hospira,cytarabine,1,12/18/10,4/22/11,Manufacturing delays,red,Manufacturing delays-- ----Manufacturing delays-- ----Raw material issues;Manufacturing delays-- ----Manufacturing delays-- ----API shortage/manufacturing delay-- ;Manufacturing delays----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays--             --            ----            ----            ----            ----            ----            ----            API shortage/manufacturing delay;Manufacturing delays--             --             --             --             --             --             --             --             --             --             --             Manufacturing delays                           --             --             --             --             --             --             --             --             --             --             --             Increased demand,,,,,,,,,,,,,
SanofiAventis,ddavp,1,7/16/10,8/28/10,Manufacturing delays,red,Manufacturing delays,,,,,,,,,,,,,
Ferring,desmopressin,1,11/12/10,4/22/11,Demand increase; Manufacturing delays,orange,n/a--Increased demand/manufacturing delays--Unanticipated increased demand-- ----Manufacturing delays-- -- -- ;n/a----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand / manufacturing delays----            ----            ----            ----            ----            Unanticipated increased demand----            ----            ----            ----             --             --            ----            ----            Manufacturing delays ;n/a--             --             --             --             --             --             --             --             --             --             Increased demand / manufacturing delays--             --             --             --             --             Unanticipated increased demand--             --             --             --                                         --             --             Manufacturing delays ,,,,,,,,,,,,,
Hospira,desmopressin,1,9/23/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand/manufacturing delays--Unanticipated increased demand-- ----Manufacturing delays-- -- -- ;n/a--Increased demand/manufacturing delays--Unanticipated increased demand-- ----Manufacturing delays-- -- -- ;n/a----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand / manufacturing delays----            ----            ----            ----            ----            Unanticipated increased demand----            ----            ----            ----             --             --            ----            ----            Manufacturing delays ;n/a--             --             --             --             --             --             --             --             --             --             Increased demand / manufacturing delays--             --             --             --             --             Unanticipated increased demand--             --             --             --                                         --             --             Manufacturing delays ,,,,,,,,,,,,,
SanofiAventis,desmopressin,1,9/23/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand/manufacturing delays--Unanticipated increased demand-- ----Manufacturing delays-- -- -- ;n/a--Increased demand/manufacturing delays--Unanticipated increased demand-- ----Manufacturing delays-- -- -- ;n/a----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand / manufacturing delays----            ----            ----            ----            ----            Unanticipated increased demand----            ----            ----            ----             --             --            ----            ----            Manufacturing delays ;n/a--             --             --             --             --             --             --             --             --             --             Increased demand / manufacturing delays--             --             --             --             --             Unanticipated increased demand--             --             --             --                                         --             --             Manufacturing delays ,,,,,,,,,,,,,
Teva,desmopressin,1,9/23/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand/manufacturing delays--Unanticipated increased demand-- ----Manufacturing delays-- -- -- ;n/a--Increased demand/manufacturing delays--Unanticipated increased demand-- ----Manufacturing delays-- -- -- ;n/a----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand / manufacturing delays----            ----            ----            ----            ----            Unanticipated increased demand----            ----            ----            ----             --             --            ----            ----            Manufacturing delays ;n/a--             --             --             --             --             --             --             --             --             --             Increased demand / manufacturing delays--             --             --             --             --             Unanticipated increased demand--             --             --             --                                         --             --             Manufacturing delays ,,,,,,,,,,,,,
APP,dexamethasone,1,3/31/11,4/22/11,Manufacturing delays,orange,Manufacturing issues--Increase in demand-- ;Manufacturing issues----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand;Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             Increase in demand,,,,,,,,,,,,,
AmericanRegent,dexamethasone,1,3/31/11,4/22/11,Manufacturing delays,orange,Manufacturing issues--Increase in demand-- ;Manufacturing issues----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand;Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             Increase in demand,,,,,,,,,,,,,
BenVenue,dexrazoxane,1,6/6/09,10/24/09,Manufacturing delays,red,Manufacturing delays;Manufacturing delays---- ---- ----Zinecard now available from Pfizer,,,,,,,,,,,,,
PfizerZinecard,dexrazoxane,1,6/6/09,10/24/09,Manufacturing delays,red,Manufacturing delays;Manufacturing delays---- ---- ----Zinecard now available from Pfizer,,,,,,,,,,,,,
Amphastar,dextrose,1,8/7/10,8/15/10,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Amphastar,dextrose,2,9/14/10,12/19/10,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Hospira,dextrose,1,7/9/10,8/15/10,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Hospira,dextrose,2,9/14/10,12/19/10,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Baxter,diltiazem,1,4/22/11,4/22/11,Demand increase,orange,Demand increase,,,,,,,,,,,,,
Hospira,diltiazem,1,4/22/11,4/22/11,Demand increase,orange,Demand increase,,,,,,,,,,,,,
Bedford,doxorubicin,1,11/18/10,4/22/11,Demand increase,orange,Increased demand,,,,,,,,,,,,,
APP,doxorubicins,1,4/14/11,4/22/11,Demand increase,orange,Increased demand----            ----            ----            ----            --            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----            ----            ----            ----             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand;Increased demand--             --             --             --                          --             --             --             --             --             --             --             Manufacturing delays--             --             --             --                           --             --             --             --             --             --             --             --             --             Increased demand,,,,,,,,,,,,,
Bedford,doxorubicins,1,11/18/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand----Manufacturing delays-- ----Increased demand ;Increased demand----Manufacturing delays-- --Increased demand ;Increased demand----            ----            ----            ----            --            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----            ----            ----            ----             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand;Increased demand--             --             --             --                          --             --             --             --             --             --             --             Manufacturing delays--             --             --             --                           --             --             --             --             --             --             --             --             --             Increased demand,,,,,,,,,,,,,
Teva,doxorubicins,1,11/18/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand----Manufacturing delays-- ----Increased demand ;Increased demand----Manufacturing delays-- --Increased demand ;Increased demand----            ----            ----            ----            --            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----            ----            ----            ----             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand;Increased demand--             --             --             --                          --             --             --             --             --             --             --             Manufacturing delays--             --             --             --                           --             --             --             --             --             --             --             --             --             Increased demand,,,,,,,,,,,,,
Lundbeck,elspar,1,4/15/10,6/20/10,Manufacturing delays,red,Manufacturing delays.,,,,,,,,,,,,,
Akorn,ephedrine,1,2/26/10,8/28/10,Manufacturing delays,red,Manufacturing delays---- ---- ---- ---- ---- --------Increase in demand.---- ---- ---- ;Manufacturing delays---- ---- ---- ---- ---- ----Increase in demand.---- ---- ---- ;Manufacturing delays.---- ---- ---- ---- ---- ----Increase in demand.---- ---- ---- ;Manufacturing delays.---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand.---- ---- ---- ;Manufacturing delays.-- -- -- -- -- -- -- --Increase in demand.-- -- -- ,,,,,,,,,,,,,
Hospira,ephedrine,1,2/26/10,8/28/10,Manufacturing delays,red,Manufacturing delays---- ---- ---- ---- ---- --------Increase in demand.---- ---- ---- ;Manufacturing delays---- ---- ---- ---- ---- ----Increase in demand.---- ---- ---- ;Manufacturing delays.---- ---- ---- ---- ---- ----Increase in demand.---- ---- ---- ;Manufacturing delays.---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand.---- ---- ---- ;Manufacturing delays.-- -- -- -- -- -- -- --Increase in demand.-- -- -- ,,,,,,,,,,,,,
Sandoz,ephedrine,1,2/26/10,8/28/10,Manufacturing delays,red,Manufacturing delays---- ---- ---- ---- ---- --------Increase in demand.---- ---- ---- ;Manufacturing delays---- ---- ---- ---- ---- ----Increase in demand.---- ---- ---- ;Manufacturing delays.---- ---- ---- ---- ---- ----Increase in demand.---- ---- ---- ;Manufacturing delays.---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand.---- ---- ---- ;Manufacturing delays.-- -- -- -- -- -- -- --Increase in demand.-- -- -- ,,,,,,,,,,,,,
AmericanRegent,epinephrine,1,8/20/10,8/28/10,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Amphastar,epinephrine,1,8/7/10,8/15/10,Demand increase,orange,Unanticipated increased demand,,,,,,,,,,,,,
Amphastar,epinephrine,2,9/14/10,12/19/10,Demand increase,orange,Unanticipated increased demand,,,,,,,,,,,,,
Amphastar(IMS),epinephrine,1,8/20/10,8/28/10,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Hospira,epinephrine,1,6/11/10,12/19/10,Demand increase,orange,Unanticipated increased demand;Unanticipated Increased Demand,,,,,,,,,,,,,
Epogen(Amgen),epoetin,1,10/9/10,12/19/10,Available,red,Centocor Ortho Biotech reports that short-term availability of the 2,4,000 unit and the 40,000 unit PROCRIT vials may be limited.----Amgen does not anticipate a disruption in the availability of EPOGEN for patients.-- --For additional information see Related Information section.-- ,,,,,,,,,,
Procrit(Centocor),epoetin,1,10/9/10,12/19/10,Available,red,Centocor Ortho Biotech reports that short-term availability of the 2,4,000 unit and the 40,000 unit PROCRIT vials may be limited.----Amgen does not anticipate a disruption in the availability of EPOGEN for patients.-- --For additional information see Related Information section.-- ,,,,,,,,,,
BauschLomb,erythromycin,1,8/14/09,2/20/10,Demand increase,orange,Increase in demand.;Increase in demand.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Product delays;Increase in demand.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Production delays;Increase in demand.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Production delays;Increase in demand.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Fera Pharmaceuticals has begun shipping Erythromycin Ophthalmic Ointment,,,,,,,,,,,,,
Fera,erythromycin,1,8/30/09,2/20/10,Demand increase,orange,Increase in demand.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Product delays;Increase in demand.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Production delays;Increase in demand.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Production delays;Increase in demand.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Fera Pharmaceuticals has begun shipping Erythromycin Ophthalmic Ointment,,,,,,,,,,,,,
Hospira,erythromycin,1,10/26/10,4/22/11,Manufacturing delays,,Manufacturing delays,,,,,,,,,,,,,
Guerbet,ethiodol,1,5/15/10,4/22/11,Discontinued,,Product has been discontinued by Nycomed US Inc.,,,,,,,,,,,,,
Nycomed,ethiodol,1,3/19/10,5/8/10,Discontinued,,Product has been discontinued.,,,,,,,,,,,,,
APP,etoposide,1,9/14/10,4/7/11,Demand increase; Manufacturing delays,orange,Increased demand-- ---- ----Manufacturing delays-- ----Manufacturing delays-- ----Increased demand-- ,,,,,,,,,,,,,
APP,etoposide,2,4/22/11,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand                           --             --             --             --                           --             Manufacturing delays--             --             --             --                           --             --             --             --             --             Manufacturing delays                           --             --             --             --             --             Increased demand,,,,,,,,,,,,,
BMS,etoposide,1,9/14/10,4/7/11,Demand increase; Manufacturing delays,orange,Increased demand-- ---- ----Manufacturing delays-- ----Manufacturing delays-- ----Increased demand-- ,,,,,,,,,,,,,
Bedford,etoposide,1,9/14/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand-- ---- ----Manufacturing delays-- ----Manufacturing delays-- ----Increased demand-- ;Increased demand--             --            ----            ----            ----            ----             --            ----            Manufacturing delays----            ----            ----            ----             --            ----            ----            ----            ----            ----            Manufacturing delays--             --            ----            ----            ----            ----            ----            Increased demand;Increased demand                           --             --             --             --                           --             Manufacturing delays--             --             --             --                           --             --             --             --             --             Manufacturing delays                           --             --             --             --             --             Increased demand,,,,,,,,,,,,,
Teva,etoposide,1,9/14/10,4/7/11,Demand increase; Manufacturing delays,orange,Increased demand-- ---- ----Manufacturing delays-- ----Manufacturing delays-- ----Increased demand-- ,,,,,,,,,,,,,
Teva,etoposide,2,4/22/11,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand                           --             --             --             --                           --             Manufacturing delays--             --             --             --                           --             --             --             --             --             Manufacturing delays                           --             --             --             --             --             Increased demand,,,,,,,,,,,,,
Genzyme,fabrazyme,1,8/26/09,4/22/11,Demand increase; Manufacturing delays,,Manufacturing delays---- ;Manufacturing delays-- ;Manufacturing delays--             ;Manufacturing delays              ,,,,,,,,,,,,,
AstraZeneca,faslodex,1,8/6/09,10/30/09,X,,Supply constraints,,,,,,,,,,,,,
ActavisTotowa,fentanyl,1,4/22/11,4/22/11,Manufacturing issues,,Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             Not Applicable; Capable of Supplying 100 % of Market Demand--             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--N/A,,,,,,,,,,,,,
Apotex,fentanyl,1,4/22/11,4/22/11,Manufacturing issues,,Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             Not Applicable; Capable of Supplying 100 % of Market Demand--             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--N/A,,,,,,,,,,,,,
Covidien,fentanyl,1,4/22/11,4/22/11,Manufacturing issues,,Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             Not Applicable; Capable of Supplying 100 % of Market Demand--             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--N/A,,,,,,,,,,,,,
Mylan,fentanyl,1,4/22/11,4/22/11,Manufacturing issues,,Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             Not Applicable; Capable of Supplying 100 % of Market Demand--             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--N/A,,,,,,,,,,,,,
Novaplus,fentanyl,1,4/22/11,4/22/11,Manufacturing issues,,Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             Not Applicable; Capable of Supplying 100 % of Market Demand--             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--N/A,,,,,,,,,,,,,
OrthoMcNeilJanssen,fentanyl,1,4/22/11,4/22/11,Manufacturing issues,,Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             Not Applicable; Capable of Supplying 100 % of Market Demand--             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--N/A,,,,,,,,,,,,,
Sandoz,fentanyl,1,4/22/11,4/22/11,Manufacturing issues,,Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             Not Applicable; Capable of Supplying 100 % of Market Demand--             --             --             --             --             --             --             --             --             --             --             --             N/A--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             N/A--N/A,,,,,,,,,,,,,
Amphastar,foscarnet,1,8/20/10,8/28/10,Demand increase,orange,Unanticipated Increased Demand,,,,,,,,,,,,,
Hospira,foscarnet,1,8/7/10,4/22/11,Demand increase; Manufacturing delays,orange,Manufacturing delays;Unanticipated Increased Demand,,,,,,,,,,,,,
APP,fosphenytoin,1,4/15/10,4/22/11,Demand increase; Manufacturing delays,orange,Not currently marketed.---- ----Manufacturing delays.---- ---- ----Not currently marketed.---- ----Increase in demand.---- ;Not currently marketed.---- ---- ---- ----Manufacturing delays.---- ---- ----Not currently marketed.---- ---- ----Increase in demand.---- ;Not currently marketed.-- -- ------------Manufacturing delays.-- --Not currently marketed.-- -- --Increase in demand.-- ;Not currently marketed.-- -- -- -- -- -- ----Manufacturing delays.-- --Not currently marketed.-- -- --Increase in demand.-- ;Not currently marketed.-- --Manufacturing delays.-- --Not currently marketed.-- -- --Increase in demand.-- ;Not currently marketed-- ----Manufacturing delays-- ----Not currently marketed-- ----Increase in demand----Increased demand-- ;Not currently marketed-- ----Manufacturing delays-- ----Not currently marketed-- ----Increase in demand----Increased demand----Newly launched product ;Not currently marketed--             --            ----            Manufacturing delays--             --            ----            Not currently marketed--             --            ----            Increase in demand--            ----            ----            ----            Increased demand--            ----            ----            ----            ----            ----            ----            Newly launched product ;Not currently marketed                           --             Manufacturing delays                           --             Not currently marketed                           --             Increase in demand             --             --             --             Increased demand             --             --             --             --             --             --             Newly launched product ,,,,,,,,,,,,,
Akorn,fosphenytoin,1,4/15/10,4/22/11,Demand increase; Manufacturing delays,orange,Not currently marketed.---- ----Manufacturing delays.---- ---- ----Not currently marketed.---- ----Increase in demand.---- ;Not currently marketed.---- ---- ---- ----Manufacturing delays.---- ---- ----Not currently marketed.---- ---- ----Increase in demand.---- ;Not currently marketed.-- -- ------------Manufacturing delays.-- --Not currently marketed.-- -- --Increase in demand.-- ;Not currently marketed.-- -- -- -- -- -- ----Manufacturing delays.-- --Not currently marketed.-- -- --Increase in demand.-- ;Not currently marketed.-- --Manufacturing delays.-- --Not currently marketed.-- -- --Increase in demand.-- ;Not currently marketed-- ----Manufacturing delays-- ----Not currently marketed-- ----Increase in demand----Increased demand-- ;Not currently marketed-- ----Manufacturing delays-- ----Not currently marketed-- ----Increase in demand----Increased demand----Newly launched product ;Not currently marketed--             --            ----            Manufacturing delays--             --            ----            Not currently marketed--             --            ----            Increase in demand--            ----            ----            ----            Increased demand--            ----            ----            ----            ----            ----            ----            Newly launched product ;Not currently marketed                           --             Manufacturing delays                           --             Not currently marketed                           --             Increase in demand             --             --             --             Increased demand             --             --             --             --             --             --             Newly launched product ,,,,,,,,,,,,,
AmericanRegent,fosphenytoin,1,2/2/11,4/22/11,Demand increase; Manufacturing delays,orange,Not currently marketed-- ----Manufacturing delays-- ----Not currently marketed-- ----Increase in demand----Increased demand----Newly launched product ;Not currently marketed--             --            ----            Manufacturing delays--             --            ----            Not currently marketed--             --            ----            Increase in demand--            ----            ----            ----            Increased demand--            ----            ----            ----            ----            ----            ----            Newly launched product ;Not currently marketed                           --             Manufacturing delays                           --             Not currently marketed                           --             Increase in demand             --             --             --             Increased demand             --             --             --             --             --             --             Newly launched product ,,,,,,,,,,,,,
Bedford,fosphenytoin,1,4/15/10,4/22/11,Demand increase; Manufacturing delays,orange,Not currently marketed.---- ----Manufacturing delays.---- ---- ----Not currently marketed.---- ----Increase in demand.---- ;Not currently marketed.---- ---- ---- ----Manufacturing delays.---- ---- ----Not currently marketed.---- ---- ----Increase in demand.---- ;Not currently marketed.-- -- ------------Manufacturing delays.-- --Not currently marketed.-- -- --Increase in demand.-- ;Not currently marketed.-- -- -- -- -- -- ----Manufacturing delays.-- --Not currently marketed.-- -- --Increase in demand.-- ;Not currently marketed.-- --Manufacturing delays.-- --Not currently marketed.-- -- --Increase in demand.-- ;Not currently marketed-- ----Manufacturing delays-- ----Not currently marketed-- ----Increase in demand----Increased demand-- ;Not currently marketed-- ----Manufacturing delays-- ----Not currently marketed-- ----Increase in demand----Increased demand----Newly launched product ;Not currently marketed--             --            ----            Manufacturing delays--             --            ----            Not currently marketed--             --            ----            Increase in demand--            ----            ----            ----            Increased demand--            ----            ----            ----            ----            ----            ----            Newly launched product ;Not currently marketed                           --             Manufacturing delays                           --             Not currently marketed                           --             Increase in demand             --             --             --             Increased demand             --             --             --             --             --             --             Newly launched product ,,,,,,,,,,,,,
Hospira,fosphenytoin,1,4/15/10,4/22/11,Demand increase; Manufacturing delays,orange,Not currently marketed.---- ----Manufacturing delays.---- ---- ----Not currently marketed.---- ----Increase in demand.---- ;Not currently marketed.---- ---- ---- ----Manufacturing delays.---- ---- ----Not currently marketed.---- ---- ----Increase in demand.---- ;Not currently marketed.-- -- ------------Manufacturing delays.-- --Not currently marketed.-- -- --Increase in demand.-- ;Not currently marketed.-- -- -- -- -- -- ----Manufacturing delays.-- --Not currently marketed.-- -- --Increase in demand.-- ;Not currently marketed.-- --Manufacturing delays.-- --Not currently marketed.-- -- --Increase in demand.-- ;Not currently marketed-- ----Manufacturing delays-- ----Not currently marketed-- ----Increase in demand----Increased demand-- ;Not currently marketed-- ----Manufacturing delays-- ----Not currently marketed-- ----Increase in demand----Increased demand----Newly launched product ;Not currently marketed--             --            ----            Manufacturing delays--             --            ----            Not currently marketed--             --            ----            Increase in demand--            ----            ----            ----            Increased demand--            ----            ----            ----            ----            ----            ----            Newly launched product ;Not currently marketed                           --             Manufacturing delays                           --             Not currently marketed                           --             Increase in demand             --             --             --             Increased demand             --             --             --             --             --             --             Newly launched product ,,,,,,,,,,,,,
WestWard,fosphenytoin,1,11/18/10,4/22/11,Demand increase; Manufacturing delays,orange,Not currently marketed-- ----Manufacturing delays-- ----Not currently marketed-- ----Increase in demand----Increased demand-- ;Not currently marketed-- ----Manufacturing delays-- ----Not currently marketed-- ----Increase in demand----Increased demand----Newly launched product ;Not currently marketed--             --            ----            Manufacturing delays--             --            ----            Not currently marketed--             --            ----            Increase in demand--            ----            ----            ----            Increased demand--            ----            ----            ----            ----            ----            ----            Newly launched product ;Not currently marketed                           --             Manufacturing delays                           --             Not currently marketed                           --             Increase in demand             --             --             --             Increased demand             --             --             --             --             --             --             Newly launched product ,,,,,,,,,,,,,
APP,furosemide,1,6/25/10,8/15/10,Demand increase; Manufacturing delays,orange,Manufacturing delays---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand;Manufacturing delays---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand;Manufacturing delays-- -- -- --Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --Increase in demand,,,,,,,,,,,,,
APP,furosemide,2,9/14/10,4/22/11,Demand increase; Manufacturing delays,orange,Manufacturing delays-- -- -- ----Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --Increase in demand;Manufacturing delays--             --             --             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --            Increase in demand;Manufacturing delays                                                       --             --             --             --             --             --             --             --             --             --             Increase in demand                                                                                                                                                                                                                                             Increase in demand,,,,,,,,,,,,,
AmericanRegent,furosemide,1,6/25/10,8/15/10,Demand increase; Manufacturing delays,orange,Manufacturing delays---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand;Manufacturing delays---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand;Manufacturing delays-- -- -- --Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --Increase in demand,,,,,,,,,,,,,
AmericanRegent,furosemide,2,9/14/10,4/22/11,Demand increase; Manufacturing delays,orange,Manufacturing delays-- -- -- ----Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --Increase in demand;Manufacturing delays--             --             --             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --            Increase in demand;Manufacturing delays                                                       --             --             --             --             --             --             --             --             --             --             Increase in demand                                                                                                                                                                                                                                             Increase in demand,,,,,,,,,,,,,
Amphastar,furosemide,1,8/20/10,8/28/10,Demand increase,orange,Unanticipated increased demand,,,,,,,,,,,,,
Hospira,furosemide,1,6/25/10,4/22/11,Manufacturing delays,,Manufacturing delays---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand;Manufacturing delays---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand;Manufacturing delays-- -- -- --Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --Increase in demand;Unanticipated increased demand;Manufacturing delays-- -- -- ----Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --Increase in demand;Manufacturing delays--             --             --             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand--             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --            Increase in demand;Manufacturing delays                                                       --             --             --             --             --             --             --             --             --             --             Increase in demand                                                                                                                                                                                                                                             Increase in demand,,,,,,,,,,,,,
Camber,gemfibrozil,1,5/27/10,6/20/10,Demand increase,orange,Increase in demand---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Change awaiting FDA approval,,,,,,,,,,,,,
Pfizer,gemfibrozil,1,5/27/10,6/20/10,Demand increase,orange,Increase in demand---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Change awaiting FDA approval,,,,,,,,,,,,,
Teva,gemfibrozil,1,5/27/10,6/20/10,Demand increase,orange,Increase in demand---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Change awaiting FDA approval,,,,,,,,,,,,,
Camber,gemifibrozil,1,3/12/10,5/21/10,Demand increase,orange,Increase in demand---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Change awaiting FDA approval,,,,,,,,,,,,,
Pfizer,gemifibrozil,1,3/12/10,5/21/10,Demand increase,orange,Increase in demand---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Change awaiting FDA approval,,,,,,,,,,,,,
Teva,gemifibrozil,1,3/12/10,5/21/10,Demand increase,orange,Increase in demand---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Change awaiting FDA approval,,,,,,,,,,,,,
Bedford,gluca,1,10/19/10,3/14/11,Manufacturing delays,,----Manufacturing delays-- --Manufacturing delays-- ;----Manufacturing delays-- ----Manufacturing delays-- ,,,,,,,,,,,,,
EliLilly,gluca,1,10/19/10,3/14/11,Manufacturing delays,,----Manufacturing delays-- --Manufacturing delays-- ;----Manufacturing delays-- ----Manufacturing delays-- ,,,,,,,,,,,,,
NovoNordisk,gluca,1,10/19/10,3/14/11,Manufacturing delays,,----Manufacturing delays-- --Manufacturing delays-- ;----Manufacturing delays-- ----Manufacturing delays-- ,,,,,,,,,,,,,
APP,haloperidol,1,6/20/10,8/15/10,Manufacturing delays,,Manufacturing delays---- ---- ---- ---- ---- ----See Related Information---- ---- ---- ---- ---- ---- ---- ----See Related Information---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays;Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- -- -- -- -- -- --Manufacturing delays;Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- --Manufacturing delays,,,,,,,,,,,,,
APP,haloperidol,2,9/14/10,4/22/11,Manufacturing delays,,Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- --Manufacturing delays;Manufacturing delays-- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- --Manufacturing delays;Manufacturing delays-- -- --See Related Information-- -- -- ----See Related Information-- -- -- -- -- -- ----Manufacturing delays;Manufacturing delays--             --             --            See Related Information--             --             --             --            ----            ----            ----            See Related Information--             --             --             --             --             --             --            ----            ----            ----            ----            Manufacturing delays;Manufacturing delays                                         See Related Information                                                       --             --             --             See Related Information                                                                                                 --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
Bedford,haloperidol,1,6/20/10,8/15/10,Manufacturing delays,,Manufacturing delays---- ---- ---- ---- ---- ----See Related Information---- ---- ---- ---- ---- ---- ---- ----See Related Information---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays;Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- -- -- -- -- -- --Manufacturing delays;Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- --Manufacturing delays,,,,,,,,,,,,,
Bedford,haloperidol,2,9/14/10,4/22/11,Manufacturing delays,,Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- --Manufacturing delays;Manufacturing delays-- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- --Manufacturing delays;Manufacturing delays-- -- --See Related Information-- -- -- ----See Related Information-- -- -- -- -- -- ----Manufacturing delays;Manufacturing delays--             --             --            See Related Information--             --             --             --            ----            ----            ----            See Related Information--             --             --             --             --             --             --            ----            ----            ----            ----            Manufacturing delays;Manufacturing delays                                         See Related Information                                                       --             --             --             See Related Information                                                                                                 --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
Hospira,haloperidol,1,8/20/10,8/28/10,Manufacturing delays,,Manufacturing delays,,,,,,,,,,,,,
OrthoMcNeilJanssen,haloperidol,1,6/20/10,8/15/10,Manufacturing delays,,Manufacturing delays---- ---- ---- ---- ---- ----See Related Information---- ---- ---- ---- ---- ---- ---- ----See Related Information---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays;Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- -- -- -- -- -- --Manufacturing delays;Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- --Manufacturing delays,,,,,,,,,,,,,
OrthoMcNeilJanssen,haloperidol,2,9/14/10,4/22/11,Manufacturing delays,,Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- --Manufacturing delays;Manufacturing delays-- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- --Manufacturing delays;Manufacturing delays-- -- --See Related Information-- -- -- ----See Related Information-- -- -- -- -- -- ----Manufacturing delays;Manufacturing delays--             --             --            See Related Information--             --             --             --            ----            ----            ----            See Related Information--             --             --             --             --             --             --            ----            ----            ----            ----            Manufacturing delays;Manufacturing delays                                         See Related Information                                                       --             --             --             See Related Information                                                                                                 --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
Teva,haloperidol,1,6/20/10,8/15/10,Manufacturing delays,,Manufacturing delays---- ---- ---- ---- ---- ----See Related Information---- ---- ---- ---- ---- ---- ---- ----See Related Information---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays;Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- -- -- -- -- -- --Manufacturing delays;Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- --Manufacturing delays,,,,,,,,,,,,,
Teva,haloperidol,2,9/14/10,4/22/11,Manufacturing delays,,Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- --Manufacturing delays;Manufacturing delays-- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- --Manufacturing delays;Manufacturing delays-- -- --See Related Information-- -- -- ----See Related Information-- -- -- -- -- -- ----Manufacturing delays;Manufacturing delays--             --             --            See Related Information--             --             --             --            ----            ----            ----            See Related Information--             --             --             --             --             --             --            ----            ----            ----            ----            Manufacturing delays;Manufacturing delays                                         See Related Information                                                       --             --             --             See Related Information                                                                                                 --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
Baxter,heparin,1,6/6/09,9/6/09,Product recall,green,Product recall,,,,,,,,,,,,,
Baxter,heparin,2,2/20/10,9/23/10,X,,Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;B. Braun now has heparin infusion solutions available---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;B. Braun now has heparin infusion solutions available-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --Shortage of finished product that meets current specification.-- -- -- -- -- -- -- -- -- -- -- --Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;B. Braun now has heparin infusion solutions available-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- ----Shortage of finished product that meets current specification.-- -- -- -- --Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.,,,,,,,,,,,,,
Bbraun,heparin,1,6/6/09,9/6/09,Product recall,green,Product recall,,,,,,,,,,,,,
Bbraun,heparin,2,2/20/10,9/23/10,X,,Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;B. Braun now has heparin infusion solutions available---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;B. Braun now has heparin infusion solutions available-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --Shortage of finished product that meets current specification.-- -- -- -- -- -- -- -- -- -- -- --Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;B. Braun now has heparin infusion solutions available-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- ----Shortage of finished product that meets current specification.-- -- -- -- --Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.,,,,,,,,,,,,,
Hospira,heparin,1,2/20/10,9/23/10,X,,Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;Shortage of Heparin Sodium drug substance that meets current qualification requirements---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;B. Braun now has heparin infusion solutions available---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Shortage of finished product that meets current specification.---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;B. Braun now has heparin infusion solutions available-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --Shortage of finished product that meets current specification.-- -- -- -- -- -- -- -- -- -- -- --Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.;B. Braun now has heparin infusion solutions available-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- ----Shortage of finished product that meets current specification.-- -- -- -- --Short supply of drug substance and unanticipated issues to implement the new USP Heparin monograph.,,,,,,,,,,,,,
Lundbeck,indocin,1,11/21/09,2/20/10,Manufacturing delays,,Manufacturing delays,,,,,,,,,,,,,
Watson,infed,1,6/6/09,8/14/09,Manufacturing delays,,Manufacturing delays,,,,,,,,,,,,,
Baxter,intravenous,1,7/3/10,4/22/11,Manufacturing delays,,Manufacturing issues---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand;Manufacturing issues-- -- -- -- -- -- -- -- -- -- -- -- -- -- --Increase in demand;Manufacturing issues-- -- -- -- -- -- -- -- -- -- -- -- -- --Baxter now has adequate supply available to meet demand.;Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             --             --            Baxter now has adequate supply available to meet demand.;Manufacturing issues                                                                                                                                                                                                   Baxter now has adequate supply available to meet demand.,,,,,,,,,,,,,
Hospira,intravenous,1,7/3/10,4/22/11,Manufacturing delays,,Manufacturing issues---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand;Manufacturing issues-- -- -- -- -- -- -- -- -- -- -- -- -- -- --Increase in demand;Manufacturing issues-- -- -- -- -- -- -- -- -- -- -- -- -- --Baxter now has adequate supply available to meet demand.;Manufacturing issues--             --             --             --             --             --             --             --             --             --             --             --             --             --            Baxter now has adequate supply available to meet demand.;Manufacturing issues                                                                                                                                                                                                   Baxter now has adequate supply available to meet demand.,,,,,,,,,,,,,
ScheringPlough,intron,1,12/7/09,6/25/10,X,,Please see attached Recall Letter,,,,,,,,,,,,,
APP,isoniazid,1,8/20/10,8/28/10,Demand increase; Manufacturing delays,orange,Manufacturing delays-- -- -- --Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --Increase in demand,,,,,,,,,,,,,
AmericanRegent,isoniazid,1,8/20/10,8/28/10,Demand increase; Manufacturing delays,orange,Manufacturing delays-- -- -- --Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --Increase in demand,,,,,,,,,,,,,
Hospira,isoniazid,1,8/20/10,8/28/10,Demand increase; Manufacturing delays,orange,Manufacturing delays-- -- -- --Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --Increase in demand,,,,,,,,,,,,,
Sandoz,isoniazid,1,6/6/09,8/15/10,Available,,Product continues to be available with short expiration dating.,,,,,,,,,,,,,
APP,leucovorin,1,8/20/10,8/28/10,Manufacturing delays,,Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- --Manufacturing delays,,,,,,,,,,,,,
Bedford,leucovorin,1,6/20/10,6/25/10,Manufacturing delays,,Manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays,,,,,,,,,,,,,
Bedford,leucovorin,2,8/20/10,8/28/10,Manufacturing delays,,Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- --Manufacturing delays,,,,,,,,,,,,,
OrthoMcNeilJanssen,leucovorin,1,8/20/10,8/28/10,Manufacturing delays,,Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- --Manufacturing delays,,,,,,,,,,,,,
Teva,leucovorin,1,6/20/10,6/25/10,Manufacturing delays,,Manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays,,,,,,,,,,,,,
Teva,leucovorin,2,8/20/10,8/28/10,Manufacturing delays,,Manufacturing delays-- -- -- -- -- --See Related Information-- -- -- -- -- -- -- --See Related Information-- -- -- -- -- -- -- -- -- --Manufacturing delays,,,,,,,,,,,,,
APP,leucovorinlevoleucovorin,1,4/14/11,4/14/11,Manufacturing delays, Inc. to temporarily import levoleucovorin 100 mg Powder for Injection manufactured by Pfizer Inc. ----            ----            Please see the Dear Healthcare Professional Letter (PDF - 159KB) for additional information.,Manufacturing delays--             --             --             --             --             --             --             --            Manufacturing delays----            ----            ----            ----             --            ----            ----            ----            ----            APP has recently launched their leucovorin injection in response to the ongoing shortage.----             --             --             --             --            ----            ----            Due to the shortage of both leucovorin and levoleucovorin products,,,,,,,,,,,,,
Bedford,leucovorinlevoleucovorin,1,7/3/10,8/15/10,Manufacturing delays,,Manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays---- ---- ---- ---- ---- ---- ----Supplies continue to be available.;Manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays---- ---- ---- ----Supplies continue to be available.;Manufacturing delays-- -- -- -- -- -- -- -- -- -- --Manufacturing delays-- -- -- --Supplies continue to be available.;Manufacturing delays-- -- -- -- -- -- -- -- -- -- ----Manufacturing delays-- -- -- ----Supplies continue to be available.,,,,,,,,,,,,,
Bedford,leucovorinlevoleucovorin,2,9/14/10,12/25/10,Manufacturing delays,,Manufacturing delays-- -- -- -- -- -- -- --Manufacturing delays-- -- -- ----Supplies continue to be available.;Manufacturing delays-- -- -- -- -- -- -- ----Manufacturing delays-- -- -- ----Supplies continue to be available.,,,,,,,,,,,,,
Bedford,leucovorinlevoleucovorin,3,1/6/11,4/22/11,Manufacturing delays, Inc. to temporarily import levoleucovorin 100 mg Powder for Injection manufactured by Pfizer Inc. --Please see the Dear Healthcare Professional Letter (PDF - 159KB) for additional information.-- ;Manufacturing delays--             --             --             --             --             --             --             --            Manufacturing delays----            ----            ----            ----             --            ----            ----            ----            ----            APP has recently launched their leucovorin injection in response to the ongoing shortage.----             --             --             --             --            ----            ----            Due to the shortage of both leucovorin and levoleucovorin products,Manufacturing delays-- -- -- -- -- -- -- ----Manufacturing delays-- ----APP has recently launched their leucovorin injection in response to the ongoing shortage.-- -- -- -- ----Supplies continue to be available.-- ;Manufacturing delays-- -- -- -- -- -- -- ----Manufacturing delays-- ----APP has recently launched their leucovorin injection in response to the ongoing shortage.-- -- -- -- ----Spectrum is working with the FDA on additional supplies - new information will be posted soon about additional supplies to help address the shortage.-- ;Manufacturing delays-- -- -- -- -- -- -- --Manufacturing delays-- ----APP has recently launched their leucovorin injection in response to the ongoing shortage.-- -- -- -- ----Due to the shortage of both leucovorin and levoleucovorin products, Inc. to temporarily import levoleucovorin 100 mg Powder for Injection manufactured by Pfizer Inc. ----            ----            Please see the Dear Healthcare Professional Letter (PDF - 159KB) for additional information.;Manufacturing delays                                                                                                               Manufacturing delays--             --             --             --                           --             --             --             --             APP has recently launched their leucovorin injection in response to the ongoing shortage.--                                                                     --             --             Due to the shortage of both leucovorin and levoleucovorin products, the FDA has utilized regulatory enforcement discretion for Spectrum Pharmaceuticals, Inc. to temporarily import levoleucovorin 100 mg Powder for Injection manufactured by Pfizer Inc. --             --             Please see the Dear Healthcare Professional Letter (PDF - 159KB) for additional information.,,,,,,,,,,
Spectrum,leucovorinlevoleucovorin,1,7/3/10,8/15/10,Manufacturing delays,,Manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays---- ---- ---- ---- ---- ---- ----Supplies continue to be available.;Manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays---- ---- ---- ----Supplies continue to be available.;Manufacturing delays-- -- -- -- -- -- -- -- -- -- --Manufacturing delays-- -- -- --Supplies continue to be available.;Manufacturing delays-- -- -- -- -- -- -- -- -- -- ----Manufacturing delays-- -- -- ----Supplies continue to be available.,,,,,,,,,,,,,
Spectrum,leucovorinlevoleucovorin,2,9/14/10,12/25/10,Manufacturing delays,,Manufacturing delays-- -- -- -- -- -- -- --Manufacturing delays-- -- -- ----Supplies continue to be available.;Manufacturing delays-- -- -- -- -- -- -- ----Manufacturing delays-- -- -- ----Supplies continue to be available.,,,,,,,,,,,,,
Spectrum,leucovorinlevoleucovorin,3,1/6/11,4/22/11,Manufacturing delays, Inc. to temporarily import levoleucovorin 100 mg Powder for Injection manufactured by Pfizer Inc. --Please see the Dear Healthcare Professional Letter (PDF - 159KB) for additional information.-- ;Manufacturing delays--             --             --             --             --             --             --             --            Manufacturing delays----            ----            ----            ----             --            ----            ----            ----            ----            APP has recently launched their leucovorin injection in response to the ongoing shortage.----             --             --             --             --            ----            ----            Due to the shortage of both leucovorin and levoleucovorin products,Manufacturing delays-- -- -- -- -- -- -- ----Manufacturing delays-- ----APP has recently launched their leucovorin injection in response to the ongoing shortage.-- -- -- -- ----Supplies continue to be available.-- ;Manufacturing delays-- -- -- -- -- -- -- ----Manufacturing delays-- ----APP has recently launched their leucovorin injection in response to the ongoing shortage.-- -- -- -- ----Spectrum is working with the FDA on additional supplies - new information will be posted soon about additional supplies to help address the shortage.-- ;Manufacturing delays-- -- -- -- -- -- -- --Manufacturing delays-- ----APP has recently launched their leucovorin injection in response to the ongoing shortage.-- -- -- -- ----Due to the shortage of both leucovorin and levoleucovorin products, Inc. to temporarily import levoleucovorin 100 mg Powder for Injection manufactured by Pfizer Inc. ----            ----            Please see the Dear Healthcare Professional Letter (PDF - 159KB) for additional information.;Manufacturing delays                                                                                                               Manufacturing delays--             --             --             --                           --             --             --             --             APP has recently launched their leucovorin injection in response to the ongoing shortage.--                                                                     --             --             Due to the shortage of both leucovorin and levoleucovorin products, the FDA has utilized regulatory enforcement discretion for Spectrum Pharmaceuticals, Inc. to temporarily import levoleucovorin 100 mg Powder for Injection manufactured by Pfizer Inc. --             --             Please see the Dear Healthcare Professional Letter (PDF - 159KB) for additional information.,,,,,,,,,,
Teva,leucovorinlevoleucovorin,1,7/3/10,8/15/10,Manufacturing delays,,Manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays---- ---- ---- ---- ---- ---- ----Supplies continue to be available.;Manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays---- ---- ---- ----Supplies continue to be available.;Manufacturing delays-- -- -- -- -- -- -- -- -- -- --Manufacturing delays-- -- -- --Supplies continue to be available.;Manufacturing delays-- -- -- -- -- -- -- -- -- -- ----Manufacturing delays-- -- -- ----Supplies continue to be available.,,,,,,,,,,,,,
Teva,leucovorinlevoleucovorin,2,9/14/10,12/25/10,Manufacturing delays,,Manufacturing delays-- -- -- -- -- -- -- --Manufacturing delays-- -- -- ----Supplies continue to be available.;Manufacturing delays-- -- -- -- -- -- -- ----Manufacturing delays-- -- -- ----Supplies continue to be available.,,,,,,,,,,,,,
Teva,leucovorinlevoleucovorin,3,1/6/11,4/22/11,Manufacturing delays, Inc. to temporarily import levoleucovorin 100 mg Powder for Injection manufactured by Pfizer Inc. --Please see the Dear Healthcare Professional Letter (PDF - 159KB) for additional information.-- ;Manufacturing delays--             --             --             --             --             --             --             --            Manufacturing delays----            ----            ----            ----             --            ----            ----            ----            ----            APP has recently launched their leucovorin injection in response to the ongoing shortage.----             --             --             --             --            ----            ----            Due to the shortage of both leucovorin and levoleucovorin products,Manufacturing delays-- -- -- -- -- -- -- ----Manufacturing delays-- ----APP has recently launched their leucovorin injection in response to the ongoing shortage.-- -- -- -- ----Supplies continue to be available.-- ;Manufacturing delays-- -- -- -- -- -- -- ----Manufacturing delays-- ----APP has recently launched their leucovorin injection in response to the ongoing shortage.-- -- -- -- ----Spectrum is working with the FDA on additional supplies - new information will be posted soon about additional supplies to help address the shortage.-- ;Manufacturing delays-- -- -- -- -- -- -- --Manufacturing delays-- ----APP has recently launched their leucovorin injection in response to the ongoing shortage.-- -- -- -- ----Due to the shortage of both leucovorin and levoleucovorin products, Inc. to temporarily import levoleucovorin 100 mg Powder for Injection manufactured by Pfizer Inc. ----            ----            Please see the Dear Healthcare Professional Letter (PDF - 159KB) for additional information.;Manufacturing delays                                                                                                               Manufacturing delays--             --             --             --                           --             --             --             --             APP has recently launched their leucovorin injection in response to the ongoing shortage.--                                                                     --             --             Due to the shortage of both leucovorin and levoleucovorin products, the FDA has utilized regulatory enforcement discretion for Spectrum Pharmaceuticals, Inc. to temporarily import levoleucovorin 100 mg Powder for Injection manufactured by Pfizer Inc. --             --             Please see the Dear Healthcare Professional Letter (PDF - 159KB) for additional information.,,,,,,,,,,
Roxane,levorphanol,1,4/15/10,4/22/11,Manufacturing delays,,Manufacturing delays.,,,,,,,,,,,,,
Baxter,lorazepam,1,4/14/11,4/22/11,Demand increase,orange,Demand increase,,,,,,,,,,,,,
Bedford,lorazepam,1,4/14/11,4/22/11,Demand increase,orange,Demand increase,,,,,,,,,,,,,
Hospira,lorazepam,1,4/22/11,4/22/11,Demand increase,orange,Demand increase,,,,,,,,,,,,,
APP,methotrexate,1,6/6/09,3/12/10,Demand increase,orange,Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ---- ----APP has product available;Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ---- ---- ---- ----APP has product available;Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ----APP has product available,,,,,,,,,,
Bedford,methotrexate,1,6/6/09,3/12/10,Demand increase,orange,Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ---- ----APP has product available;Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ---- ---- ---- ----APP has product available;Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ----APP has product available,,,,,,,,,,
Ebewe,methotrexate,1,6/6/09,3/12/10,Demand increase,orange,Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ---- ----APP has product available;Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ---- ---- ---- ----APP has product available;Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ----APP has product available,,,,,,,,,,
GeneraMedix,methotrexate,1,6/6/09,3/12/10,Demand increase,orange,Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ---- ----APP has product available;Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ---- ---- ---- ----APP has product available;Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ----APP has product available,,,,,,,,,,
Hospira,methotrexate,1,6/6/09,3/12/10,Demand increase,orange,Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ---- ----APP has product available;Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ---- ---- ---- ----APP has product available;Bedford Laboratories- manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ----Ebewe Parenta Pharmaceuticals, Inc. has all presentations available.---- ---- ---- ---- ----Hospira- unable to meet demand---- ---- ---- ---- ---- ----GeneraMedix- increase in demand---- ---- ---- ---- ----APP has product available,,,,,,,,,,
Covidien,methylphenidate,1,4/7/11,4/22/11,Demand increase; API limitations,orange,Capacity constraints and receiving API orders ----API constraints----Increase in demand----n/a;Capacity constraints and receiving API orders--             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            API constraints--            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand--            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            n/a;Capacity constraints and receiving API orders                           --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             API constraints             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Increase in demand             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             n/a,,,,,,,,,,,,,
Sandoz,methylphenidate,1,4/7/11,4/22/11,Demand increase; API limitations,orange,Capacity constraints and receiving API orders ----API constraints----Increase in demand----n/a;Capacity constraints and receiving API orders--             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            API constraints--            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand--            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            n/a;Capacity constraints and receiving API orders                           --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             API constraints             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Increase in demand             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             n/a,,,,,,,,,,,,,
UCB,methylphenidate,1,4/7/11,4/22/11,Demand increase; API limitations,orange,Capacity constraints and receiving API orders ----API constraints----Increase in demand----n/a;Capacity constraints and receiving API orders--             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            API constraints--            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand--            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            n/a;Capacity constraints and receiving API orders                           --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             API constraints             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Increase in demand             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             n/a,,,,,,,,,,,,,
Watson,methylphenidate,1,4/7/11,4/22/11,Demand increase; API limitations,orange,Capacity constraints and receiving API orders ----API constraints----Increase in demand----n/a;Capacity constraints and receiving API orders--             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            API constraints--            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand--            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            n/a;Capacity constraints and receiving API orders                           --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             API constraints             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             Increase in demand             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             --             n/a,,,,,,,,,,,,,
Baxter,metoclopramide,1,2/9/11,4/22/11,Demand increase,orange,Increased Demand-- ----Hospira discontinued metoclopramide ampules in February,2010, and Carpuject syringes in May, 2009.;Increased Demand--             --             --             --             --                           --             --             --             --             --             --             --             Hospira discontinued metoclopramide ampules in February,2010, and Carpuject syringes in May,2009,,,,,,,
Hospira,metoclopramide,1,2/9/11,4/22/11,Demand increase,orange,Increased Demand-- ----Hospira discontinued metoclopramide ampules in February,2010, and Carpuject syringes in May, 2009.;Increased Demand--             --             --             --             --                           --             --             --             --             --             --             --             Hospira discontinued metoclopramide ampules in February,2010, and Carpuject syringes in May,2009,,,,,,,
Teva,metoclopramide,1,2/9/11,4/22/11,Demand increase,orange,Increased Demand-- ----Hospira discontinued metoclopramide ampules in February,2010, and Carpuject syringes in May, 2009.;Increased Demand--             --             --             --             --                           --             --             --             --             --             --             --             Hospira discontinued metoclopramide ampules in February,2010, and Carpuject syringes in May,2009,,,,,,,
Sandoz,mexiletine,1,8/20/10,8/28/10,Available,,Product continues to be available with short expiration dating.,,,,,,,,,,,,,
Teva,mexiletine,1,2/14/10,4/22/11,Manufacturing delays,,Manufacturing Delays,,,,,,,,,,,,,
Accord,mitomycin,1,7/5/09,11/12/10,Manufacturing delays,,Manufacturing delays---- ----Accord has the 5 mg vials (NDC number: 16729-0115-05) in limited quantities. The 20mg vials (NDC 16729-0108-11) will be available by mid-July.;Manufacturing delays---- ---- ;Manufacturing delays-- -- ,,,,,,,,,,,,,
Bedford,mitomycin,1,8/20/10,8/28/10,Manufacturing delays,,Manufacturing delays-- -- -- -- -- -- -- -- -- -- ----Manufacturing delays-- -- -- ----Supplies continue to be available.,,,,,,,,,,,,,
BenVenue,mitomycin,1,6/6/09,11/12/10,Manufacturing delays,,Manufacturing delays;Manufacturing delays---- ----Accord has the 5 mg vials (NDC number: 16729-0115-05) in limited quantities. The 20mg vials (NDC 16729-0108-11) will be available by mid-July.;Manufacturing delays---- ---- ;Manufacturing delays-- -- ,,,,,,,,,,,,,
Spectrum,mitomycin,1,8/20/10,8/28/10,Manufacturing delays,,Manufacturing delays-- -- -- -- -- -- -- -- -- -- ----Manufacturing delays-- -- -- ----Supplies continue to be available.,,,,,,,,,,,,,
Teva,mitomycin,1,8/20/10,8/28/10,Manufacturing delays,,Manufacturing delays-- -- -- -- -- -- -- -- -- -- ----Manufacturing delays-- -- -- ----Supplies continue to be available.,,,,,,,,,,,,,
Amphastar,morphine,1,8/20/10,4/14/11,Manufacturing delays,,Manufacturing delays--Increased demand--Manufacturing delays--;Manufacturing delays--Increased demand--Manufacturing delays-- ;Manufacturing delays----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----             ,,,,,,,,,,,,,
Baxter,morphine,1,8/20/10,4/14/11,Manufacturing delays,,Manufacturing delays--Increased demand--Manufacturing delays--;Manufacturing delays--Increased demand--Manufacturing delays-- ;Manufacturing delays----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----             ,,,,,,,,,,,,,
Hospira,morphine,1,8/20/10,4/14/11,Manufacturing delays,,Manufacturing delays--Increased demand--Manufacturing delays--;Manufacturing delays--Increased demand--Manufacturing delays-- ;Manufacturing delays----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays----             ,,,,,,,,,,,,,
Glennmark,morphinesulfate,1,6/6/09,10/6/09,Demand increase,orange,Roxane- has product available. See information in Related Information section.----Mallinckrodt- Increased demand due to another manufacturer leaving the market.---- ---- ---- ---- ---- ---- ---- ---- ---- ----Lannett-Increased demand due to another manufacturer leaving the market.----------------Glenmark- Increased demand due to another manufacturer leaving the market.,,,,,,,,,,,,,
Lannett,morphinesulfate,1,6/6/09,10/6/09,Demand increase,orange,Roxane- has product available. See information in Related Information section.----Mallinckrodt- Increased demand due to another manufacturer leaving the market.---- ---- ---- ---- ---- ---- ---- ---- ---- ----Lannett-Increased demand due to another manufacturer leaving the market.----------------Glenmark- Increased demand due to another manufacturer leaving the market.,,,,,,,,,,,,,
Mallinckrodt,morphinesulfate,1,6/6/09,10/6/09,Demand increase,orange,Roxane- has product available. See information in Related Information section.----Mallinckrodt- Increased demand due to another manufacturer leaving the market.---- ---- ---- ---- ---- ---- ---- ---- ---- ----Lannett-Increased demand due to another manufacturer leaving the market.----------------Glenmark- Increased demand due to another manufacturer leaving the market.,,,,,,,,,,,,,
Roxane,morphinesulfate,1,6/6/09,10/6/09,Available,,Roxane- has product available. See information in Related Information section.----Mallinckrodt- Increased demand due to another manufacturer leaving the market.---- ---- ---- ---- ---- ---- ---- ---- ---- ----Lannett-Increased demand due to another manufacturer leaving the market.----------------Glenmark- Increased demand due to another manufacturer leaving the market.,,,,,,,,,,,,,
Lundbeck,mustargen,1,12/20/09,1/17/10,Manufacturing delays,,Manufacturing Delays,,,,,,,,,,,,,
Lundbeck,mustargen,2,3/16/10,4/22/11,X,,See Related Information.;See Related Information,,,,,,,,,,,,,
Baxter,mvi,1,3/26/10,4/22/11,Demand increase; Manufacturing delays,orange,Manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand;Manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand;Manufacturing delays relative to all adult formulations; Hospira is working to restore adequate supply, no timing is available.-- -- --Increase in demand;Manufacturing delays relative to all adult formulations; Hospira is working to restore adequate supply, however, no timing is available.-- --Manufacturing delays;Manufacturing delays relative to all adult formulations; Hospira is working to restore adequate supply, however, no timing is available.--             --            Manufacturing delays;Manufacturing delays relative to all adult formulations; Hospira is working to restore adequate supply, however, no timing is available.                           Manufacturing delays,,,,,,
Hospira,mvi,1,3/26/10,4/22/11,Demand increase; Manufacturing delays,orange,Manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand;Manufacturing delays---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand;Manufacturing delays relative to all adult formulations; Hospira is working to restore adequate supply, no timing is available.-- -- --Increase in demand;Manufacturing delays relative to all adult formulations; Hospira is working to restore adequate supply, however, no timing is available.-- --Manufacturing delays;Manufacturing delays relative to all adult formulations; Hospira is working to restore adequate supply, however, no timing is available.--             --            Manufacturing delays;Manufacturing delays relative to all adult formulations; Hospira is working to restore adequate supply, however, no timing is available.                           Manufacturing delays,,,,,,
Hospira,nalbuphine,1,10/9/10,4/22/11,Manufacturing delays,,Manufacturing delays,,,,,,,,,,,,,
Amphastar,naloxone,1,6/25/10,12/25/10,Manufacturing delays,,See related information section---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays;See related information section-- -- -- -- -- -- -- -- -- -- -- --Manufacturing delays;See related information section-- -- -- -- -- -- -- --Manufacturing delays,,,,,,,,,,,,,
Hospira,naloxone,1,6/25/10,12/25/10,Manufacturing delays,,See related information section---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing delays;See related information section-- -- -- -- -- -- -- -- -- -- -- --Manufacturing delays;See related information section-- -- -- -- -- -- -- --Manufacturing delays,,,,,,,,,,,,,
Lundbeck,neoprofen,1,7/30/10,4/22/11,Quality issue,,Failure to meet a visible particulate quality specification.,,,,,,,,,,,,,
APP,neostigmine,1,4/14/11,4/14/11,Demand increase,orange,Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand,,,,,,,,,,,,,
AmericanRegent(Luitpold),neostigmine,1,3/11/11,4/22/11,Demand increase,orange,Increased demand--Increased demand--Increased demand-- ;Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand;Increased demand--             --             --             --             --             --             --             --             --             Increased demand--             --             --             --             --             --             --             --             --             --             --             --             Increased demand,,,,,,,,,,,,,
Baxter,neostigmine,1,3/11/11,4/22/11,Demand increase,orange,Increased demand--Increased demand--Increased demand-- ;Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increased demand;Increased demand--             --             --             --             --             --             --             --             --             Increased demand--             --             --             --             --             --             --             --             --             --             --             --             Increased demand,,,,,,,,,,,,,
UCB,neupro,1,6/6/09,4/22/11,X,,UCB has recalled all domestic lots,,,,,,,,,,,,,
Abbott,nimbex,1,4/30/10,7/3/10,Demand increase,orange,Unexpected Increased Demand and Manufacturing Delays,,,,,,,,,,,,,
Baxter,nitroglycerin,1,2/17/11,4/22/11,Manufacturing delays,,Manufacturing delays-- ----Manufacturing delays -- ;Manufacturing delays----            ----            ----            ----            ----             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays;Manufacturing delays--             --             --             --             --                           --             --             --             --             --             --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
Hospira,nitroglycerin,1,2/17/11,4/22/11,Manufacturing delays,,Manufacturing delays-- ----Manufacturing delays -- ;Manufacturing delays----            ----            ----            ----            ----             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays;Manufacturing delays--             --             --             --             --                           --             --             --             --             --             --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
Luitpold,nitroglycerins,1,2/17/11,3/14/11,Manufacturing delays,,Manufacturing delays,,,,,,,,,,,,,
Pfizer,nitrostat,1,6/6/09,1/17/10,Demand increase,orange,Increase in demand,,,,,,,,,,,,,
Bedford,norepinephrine,1,2/2/11,4/22/11,Demand increase; Manufacturing delays,orange,Manufacturing delays-- ----Increase in demand-- -- -- ----Teva temporarily discontinued norepinephrine in June 2010.;Manufacturing delays----            ----            ----            ----             --            ----            ----            ----            ----            Increase in demand----            ----            ----             --             --             --            ----            ----            ----            ----            ----            ----            ----            ----            Teva temporarily discontinued norepinephrine in June 2010.;Manufacturing delays--             --             --             --                           --             --             --             --             Increase in demand--             --             --                                                       --             --             --             --             --             --             --             --             Teva temporarily discontinued norepinephrine in June 2010.,,,,,,,,,,,,,
Hospira,norepinephrine,1,2/2/11,4/22/11,Demand increase; Manufacturing delays,orange,Manufacturing delays-- ----Increase in demand-- -- -- ----Teva temporarily discontinued norepinephrine in June 2010.;Manufacturing delays----            ----            ----            ----             --            ----            ----            ----            ----            Increase in demand----            ----            ----             --             --             --            ----            ----            ----            ----            ----            ----            ----            ----            Teva temporarily discontinued norepinephrine in June 2010.;Manufacturing delays--             --             --             --                           --             --             --             --             Increase in demand--             --             --                                                       --             --             --             --             --             --             --             --             Teva temporarily discontinued norepinephrine in June 2010.,,,,,,,,,,,,,
Teva,norepinephrine,1,2/2/11,4/22/11,Demand increase; Manufacturing delays,orange,Manufacturing delays-- ----Increase in demand-- -- -- ----Teva temporarily discontinued norepinephrine in June 2010.;Manufacturing delays----            ----            ----            ----             --            ----            ----            ----            ----            Increase in demand----            ----            ----             --             --             --            ----            ----            ----            ----            ----            ----            ----            ----            Teva temporarily discontinued norepinephrine in June 2010.;Manufacturing delays--             --             --             --                           --             --             --             --             Increase in demand--             --             --                                                       --             --             --             --             --             --             --             --             Teva temporarily discontinued norepinephrine in June 2010.,,,,,,,,,,,,,
Pfizer,norpace,1,11/15/09,1/11/10,Demand increase,orange,Increase in demand,,,,,,,,,,,,,
Covidien,octreoscan,1,1/25/10,2/10/10,Product recall,green,Product recall,,,,,,,,,,,,,
Gate,orap,1,7/31/09,8/14/09,Manufacturing delays,,Manufacturing Delays,,,,,,,,,,,,,
Humco,ora-sweet,1,9/27/09,10/6/09,X,,See information in Related Information section.---- ---- ---- ---- ---- ---- ,,,,,,,,,,,,,
Paddock,ora-sweet,1,9/27/09,10/6/09,X,,See information in Related Information section.---- ---- ---- ---- ---- ---- ,,,,,,,,,,,,,
Valeant,oxsoralen,1,3/19/10,4/22/11,Manufacturing delays,,Manufacturing delays---- ;Manufacturing delays-- ;Manufacturing delays ,,,,,,,,,,,,,
Valeant,oxsoralen-ultra,1,3/19/10,4/22/11,Manufacturing delays,,Manufacturing delays---- ;Manufacturing delays-- ;Manufacturing delays--             ;Manufacturing delays              ,,,,,,,,,,,,,
ActavisTotowa,oxycodone,1,6/6/09,9/6/09,Demand increase,orange,Increase in demand related to product recalls by other manufacturers----Visit: FDA News,,,,,,,,,,,,,
Lannett,oxycodone,1,10/9/10,11/12/10,Raw material constraints,,Raw material constraints,,,,,,,,,,,,,
Mallinckrodt,oxycodone,1,6/6/09,9/6/09,Demand increase,orange,Increase in demand related to product recalls by other manufacturers----Visit: FDA News,,,,,,,,,,,,,
Sun,oxycodone,1,6/6/09,9/6/09,Demand increase,orange,Increase in demand related to product recalls by other manufacturers----Visit: FDA News,,,,,,,,,,,,,
Vintage,oxycodone,1,6/6/09,9/6/09,Demand increase,orange,Increase in demand related to product recalls by other manufacturers----Visit: FDA News,,,,,,,,,,,,,
Xanodyne,oxycodone,1,6/6/09,9/6/09,Demand increase,orange,Increase in demand related to product recalls by other manufacturers----Visit: FDA News,,,,,,,,,,,,,
Hospira,pancuronium,1,5/27/10,8/15/10,Demand increase,orange,Teva initiated withdrawal of multiple lots of pancuronium injection from the market on 5/4/10.---- ----Increased demand;Teva initiated withdrawal of multiple lots of pancuronium injection from the market on 5/4/10.---- ---- ----Increased demand;Teva initiated withdrawal of multiple lots of pancuronium injection from the market on 5/4/10.-- -- --Increased demand,,,,,,,,,,,,,
Hospira,pancuronium,2,10/9/10,1/26/11,Demand increase,orange,Teva initiated withdrawal of multiple lots of pancuronium injection from the market on 5/4/10.-- -- --Increased demand,,,,,,,,,,,,,
Teva,pancuronium,1,5/27/10,8/15/10,Product recall,green,Teva initiated withdrawal of multiple lots of pancuronium injection from the market on 5/4/10.---- ----Increased demand;Teva initiated withdrawal of multiple lots of pancuronium injection from the market on 5/4/10.---- ---- ----Increased demand;Teva initiated withdrawal of multiple lots of pancuronium injection from the market on 5/4/10.-- -- --Increased demand,,,,,,,,,,,,,
Teva,pancuronium,2,10/9/10,1/26/11,Demand increase,orange,Teva initiated withdrawal of multiple lots of pancuronium injection from the market on 5/4/10.-- -- --Increased demand,,,,,,,,,,,,,
Hospira,pentothal,1,11/6/09,1/19/11,Manufacturing issue,,Manufacturing issue,,,,,,,,,,,,,
Axcan,photofrin,1,10/9/10,10/9/10,FDA Review,,Pending supplement under review with FDA,,,,,,,,,,,,,
Hospira,procainamide,1,11/18/10,4/22/11,Manufacturing delays,,Manufacturing delays,,,,,,,,,,,,,
APP,propofol,1,10/30/09,4/22/11,Demand increase; product recall,green,Increase in demand---- ---- --------Recent recall of specific lots has led to increased demand.---- ---- --------Increase in demand.;Increase in demand---- ---- ---- ---- ---- ---- ----Recent recall of specific lots has led to increased demand.---- ---- --------Increase in demand.;Increase in demand---- ---- ---- ---- ---- ---- ----Recent recall of specific lots has led to increased demand.---- ---- ---- ---- ---- ---- ----Increase in demand.;Teva Pharmaceuticals does not currently have propofol available. Teva manufactures propofol injection 10 mg/mL in 20 mL vials (NDC 00703-2856-04), 50 mL vials (NDC 00409-4699-33), and 100 mL vials (NDC 00409-4699-24).---- ----Please see information on availability in the Related Information section.;Teva Pharmaceuticals recalled specific lots in fall 2009 due to possible sterility issues. Teva has recently released some propofol 20ml, 50ml and 100ml vials and expects additional quantities over the coming months. Teva manufactures propofol injection 10 mg/mL in 20 mL vials (NDC 00703-2856-04), 50 mL vials (NDC 00703-2858-08), and 100 mL vials (NDC 00703-2859-03).---- ----Hospira Pharmaceuticals recalled specific lots due to presence of particulate matter in vials. Hospira has released some propofol 20ml, 50ml and 100ml and expects additional quantities in the coming months. Hospira manufactures Propofol injection 10 mg/mL, in 20 mL vials (NDC 00409-4699-30), 50 mL vials (NDC 00409-4699-33), and 100 mL vials (NDC 00409-4699-24).---- ----APP has increased production in response to the increased demand. Please see information on availability in the Related Information section.;Teva Pharmaceuticals recalled specific lots in fall 2009 due to possible sterility issues.---- ----Hospira Pharmaceuticals recalled specific lots due to presence of particulate matter in vials. Hospira has released some propofol 20ml, 50ml and 100ml and expects additional quantities in the coming months. Hospira manufactures Propofol injection 10 mg/mL, in 20 mL vials (NDC 00409-4699-30), 50 mL vials (NDC 00409-4699-33), and 100 mL vials (NDC 00409-4699-24).---- ----APP has increased production in response to the increased demand. Please see information on availability in the Related Information section.;Teva Pharmaceuticals has discontinued their propofol injection.---- ----Hospira Inc. recalled specific lots because some containers may contain particulate matter. Hospira has implemented improvements to its manufacturing process and is coordinating with the FDA to begin distribution of propofol manufactured under a new process as soon as possible.---- ----APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section;Teva Pharmaceuticals has discontinued their propofol injection.-- --Hospira Inc. recalled specific lots because some containers may contain particulate matter. Hospira has implemented improvements to its manufacturing process and is coordinating with the FDA to begin distribution of propofol manufactured under a new process as soon as possible.-- --APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section;Teva Pharmaceuticals has discontinued their propofol injection.-- --Hospira is beginning to release a limited number of batches of propofol. Further delivery information will be forthcoming-- --APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section;Teva Pharmaceuticals has discontinued their propofol injection.--             --            Hospira is beginning to release a limited number of batches of propofol. Further delivery information will be forthcoming--             --            APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section;Teva Pharmaceuticals has discontinued their propofol injection.                           Hospira is beginning to release a limited number of batches of propofol. Further delivery information will be forthcoming                           APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section
Hospira,propofol,1,10/30/09,4/22/11,Demand increase; product recall,green,Increase in demand---- ---- --------Recent recall of specific lots has led to increased demand.---- ---- --------Increase in demand.;Increase in demand---- ---- ---- ---- ---- ---- ----Recent recall of specific lots has led to increased demand.---- ---- --------Increase in demand.;Increase in demand---- ---- ---- ---- ---- ---- ----Recent recall of specific lots has led to increased demand.---- ---- ---- ---- ---- ---- ----Increase in demand.;Teva Pharmaceuticals does not currently have propofol available. Teva manufactures propofol injection 10 mg/mL in 20 mL vials (NDC 00703-2856-04), 50 mL vials (NDC 00409-4699-33), and 100 mL vials (NDC 00409-4699-24).---- ----Please see information on availability in the Related Information section.;Teva Pharmaceuticals recalled specific lots in fall 2009 due to possible sterility issues. Teva has recently released some propofol 20ml, 50ml and 100ml vials and expects additional quantities over the coming months. Teva manufactures propofol injection 10 mg/mL in 20 mL vials (NDC 00703-2856-04), 50 mL vials (NDC 00703-2858-08), and 100 mL vials (NDC 00703-2859-03).---- ----Hospira Pharmaceuticals recalled specific lots due to presence of particulate matter in vials. Hospira has released some propofol 20ml, 50ml and 100ml and expects additional quantities in the coming months. Hospira manufactures Propofol injection 10 mg/mL, in 20 mL vials (NDC 00409-4699-30), 50 mL vials (NDC 00409-4699-33), and 100 mL vials (NDC 00409-4699-24).---- ----APP has increased production in response to the increased demand. Please see information on availability in the Related Information section.;Teva Pharmaceuticals recalled specific lots in fall 2009 due to possible sterility issues.---- ----Hospira Pharmaceuticals recalled specific lots due to presence of particulate matter in vials. Hospira has released some propofol 20ml, 50ml and 100ml and expects additional quantities in the coming months. Hospira manufactures Propofol injection 10 mg/mL, in 20 mL vials (NDC 00409-4699-30), 50 mL vials (NDC 00409-4699-33), and 100 mL vials (NDC 00409-4699-24).---- ----APP has increased production in response to the increased demand. Please see information on availability in the Related Information section.;Teva Pharmaceuticals has discontinued their propofol injection.---- ----Hospira Inc. recalled specific lots because some containers may contain particulate matter. Hospira has implemented improvements to its manufacturing process and is coordinating with the FDA to begin distribution of propofol manufactured under a new process as soon as possible.---- ----APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section;Teva Pharmaceuticals has discontinued their propofol injection.-- --Hospira Inc. recalled specific lots because some containers may contain particulate matter. Hospira has implemented improvements to its manufacturing process and is coordinating with the FDA to begin distribution of propofol manufactured under a new process as soon as possible.-- --APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section;Teva Pharmaceuticals has discontinued their propofol injection.-- --Hospira is beginning to release a limited number of batches of propofol. Further delivery information will be forthcoming-- --APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section;Teva Pharmaceuticals has discontinued their propofol injection.--             --            Hospira is beginning to release a limited number of batches of propofol. Further delivery information will be forthcoming--             --            APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section;Teva Pharmaceuticals has discontinued their propofol injection.                           Hospira is beginning to release a limited number of batches of propofol. Further delivery information will be forthcoming                           APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section
Teva,propofol,1,10/30/09,4/22/11,Demand increase; product recall,green,Increase in demand---- ---- --------Recent recall of specific lots has led to increased demand.---- ---- --------Increase in demand.;Increase in demand---- ---- ---- ---- ---- ---- ----Recent recall of specific lots has led to increased demand.---- ---- --------Increase in demand.;Increase in demand---- ---- ---- ---- ---- ---- ----Recent recall of specific lots has led to increased demand.---- ---- ---- ---- ---- ---- ----Increase in demand.;Teva Pharmaceuticals does not currently have propofol available. Teva manufactures propofol injection 10 mg/mL in 20 mL vials (NDC 00703-2856-04), 50 mL vials (NDC 00409-4699-33), and 100 mL vials (NDC 00409-4699-24).---- ----Please see information on availability in the Related Information section.;Teva Pharmaceuticals recalled specific lots in fall 2009 due to possible sterility issues. Teva has recently released some propofol 20ml, 50ml and 100ml vials and expects additional quantities over the coming months. Teva manufactures propofol injection 10 mg/mL in 20 mL vials (NDC 00703-2856-04), 50 mL vials (NDC 00703-2858-08), and 100 mL vials (NDC 00703-2859-03).---- ----Hospira Pharmaceuticals recalled specific lots due to presence of particulate matter in vials. Hospira has released some propofol 20ml, 50ml and 100ml and expects additional quantities in the coming months. Hospira manufactures Propofol injection 10 mg/mL, in 20 mL vials (NDC 00409-4699-30), 50 mL vials (NDC 00409-4699-33), and 100 mL vials (NDC 00409-4699-24).---- ----APP has increased production in response to the increased demand. Please see information on availability in the Related Information section.;Teva Pharmaceuticals recalled specific lots in fall 2009 due to possible sterility issues.---- ----Hospira Pharmaceuticals recalled specific lots due to presence of particulate matter in vials. Hospira has released some propofol 20ml, 50ml and 100ml and expects additional quantities in the coming months. Hospira manufactures Propofol injection 10 mg/mL, in 20 mL vials (NDC 00409-4699-30), 50 mL vials (NDC 00409-4699-33), and 100 mL vials (NDC 00409-4699-24).---- ----APP has increased production in response to the increased demand. Please see information on availability in the Related Information section.;Teva Pharmaceuticals has discontinued their propofol injection.---- ----Hospira Inc. recalled specific lots because some containers may contain particulate matter. Hospira has implemented improvements to its manufacturing process and is coordinating with the FDA to begin distribution of propofol manufactured under a new process as soon as possible.---- ----APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section;Teva Pharmaceuticals has discontinued their propofol injection.-- --Hospira Inc. recalled specific lots because some containers may contain particulate matter. Hospira has implemented improvements to its manufacturing process and is coordinating with the FDA to begin distribution of propofol manufactured under a new process as soon as possible.-- --APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section;Teva Pharmaceuticals has discontinued their propofol injection.-- --Hospira is beginning to release a limited number of batches of propofol. Further delivery information will be forthcoming-- --APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section;Teva Pharmaceuticals has discontinued their propofol injection.--             --            Hospira is beginning to release a limited number of batches of propofol. Further delivery information will be forthcoming--             --            APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section;Teva Pharmaceuticals has discontinued their propofol injection.                           Hospira is beginning to release a limited number of batches of propofol. Further delivery information will be forthcoming                           APP has increased production in response to the increased demand. Please see additional information on availability in the Related Information section
Sandoz,regonol,1,2/9/11,3/19/11,Manufacturing delays,,Manufacturing delays-- ,,,,,,,,,,,,,
Guardian,renacidin,1,2/2/11,4/22/11,Manufacturing delays,,Manufacturing delays,,,,,,,,,,,,,
Merck,sinemet,1,2/9/11,2/19/11,X,,See Related Information,,,,,,,,,,,,,
APP,sodiumc,1,2/9/11,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand--Increase in demand--Manufacturing delays-- ;Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays;Increased demand--             --             --             --             --             --             --             --             --             --             --             Increase in demand--             --             --             --             --             --             --             --             --             --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
AmericanRegent,sodiumc,1,2/9/11,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand--Increase in demand--Manufacturing delays-- ;Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays;Increased demand--             --             --             --             --             --             --             --             --             --             --             Increase in demand--             --             --             --             --             --             --             --             --             --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
Hospira,sodiumc,1,2/9/11,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand--Increase in demand--Manufacturing delays-- ;Increased demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Increase in demand----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            ----            Manufacturing delays;Increased demand--             --             --             --             --             --             --             --             --             --             --             Increase in demand--             --             --             --             --             --             --             --             --             --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
APP,sodiumci,1,2/9/11,4/22/11,Demand increase,orange,Increase in demand-- ----Increased demand-- ;Increase in demand----            ----            ----            ----             --            ----            ----            ----            Increased demand ;Increase in demand--             --             --             --                           --             --             --             Increased demand ,,,,,,,,,,,,,
AmericanRegent,sodiumci,1,4/14/11,4/14/11,Demand increase,orange,Increase in demand----            ----            ----            ----             --            ----            ----            ----            Increased demand ,,,,,,,,,,,,,
Hospira,sodiumci,1,2/9/11,4/22/11,Demand increase,orange,Increase in demand-- ----Increased demand-- ;Increase in demand----            ----            ----            ----             --            ----            ----            ----            Increased demand ;Increase in demand--             --             --             --                           --             --             --             Increased demand ,,,,,,,,,,,,,
Hospira,succinylcholine,1,8/28/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand--Manufacturing delays--;Increased demand--Manufacturing delays-- ;Increased demand----            ----            ----            ----            ----            ----            Manufacturing delays;Increased demand--             --             --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
Sandoz,succinylcholine,1,8/28/10,4/22/11,Demand increase; Manufacturing delays,orange,Increased demand--Manufacturing delays--;Increased demand--Manufacturing delays-- ;Increased demand----            ----            ----            ----            ----            ----            Manufacturing delays;Increased demand--             --             --             --             --             --             Manufacturing delays,,,,,,,,,,,,,
Hospira,sulfamethoxazole,1,8/20/10,9/23/10,Demand increase,orange,Teva initiated withdrawal of multiple lots of pancuronium injection from the market on 5/4/10.-- -- --Increased demand,,,,,,,,,,,,,
Teva,sulfamethoxazole,1,5/27/10,4/22/11,Product recall,green,Teva recalled Lot #31308526B/Exp. Date 9/12 of SMX/TMP Injection 10 ml vials to the retail level because some vials may have defective crimps. All sizes of vials are currently unavailable.;Teva recalled Lot #31308526B/Exp. Date 9/12 of SMX/TMP Injection 10 ml vials to the retail level because some vials may have defective crimps.;Teva initiated withdrawal of multiple lots of pancuronium injection from the market on 5/4/10.-- -- --Increased demand,,,,,,,,,,,,,
Genentech,tamiflu,1,1/19/11,4/22/11,Demand increase,orange,Increased demand,,,,,,,,,,,,,
Roche,tamiflu,1,10/10/09,2/5/10,X,,See Related Information Section,,,,,,,,,,,,,
Covidien,technetium,1,6/6/09,12/19/10,Source issues,,Reduced supply due to material sourcing issues.,,,,,,,,,,,,,
Lantheus,technetium,1,6/6/09,12/19/10,Source issues,,Reduced supply due to material sourcing issues.,,,,,,,,,,,,,
Bedford,thiotepa,1,11/21/09,3/12/10,Manufacturing delays,,Manufacturing delays---- ,,,,,,,,,,,,,
Bedford,thiotepa,2,3/31/11,4/22/11,X,,unspecified;unspecified--See related information section,,,,,,,,,,,,,
Genzyme,thyrogen,1,5/27/10,11/26/10,X,,Please see information in Related Information section.,,,,,,,,,,,,,
Forest,thyroid,1,2/14/10,4/22/11,Manufacturing issues,,Forest reports manufacturing issues involving the raw material and RLC reports increased demand. FDA has not ordered Forest or RLC to remove these thyroid (desiccated) tablets from the market.,,,,,,,,,,,,,
RLC,thyroid,1,2/14/10,4/22/11,Manufacturing issues,,Forest reports manufacturing issues involving the raw material and RLC reports increased demand. FDA has not ordered Forest or RLC to remove these thyroid (desiccated) tablets from the market.,,,,,,,,,,,,,
Forest,thyrolar,1,1/11/10,4/22/11,Manufacturing delays,,Manufacturing delays,,,,,,,,,,,,,
Pfizer,tikosyn,1,11/27/09,1/11/10,Manufacturing delays,,Manufacturing delays,,,,,,,,,,,,,
Sandoz,triamcinolone,1,6/6/09,7/5/09,Manufacturing delays,,Manufacturing Delays,,,,,,,,,,,,,
Hospira,tromethamine,1,10/26/10,4/22/11,Manufacturing delays,,Manufacturing delays,,,,,,,,,,,,,
Indevus,valstar,1,6/6/09,9/6/09,Discontinued,,Product was previously discontinued,,,,,,,,,,,,,
Bedford,vecuronium,1,11/21/09,4/22/11,Demand increase; Manufacturing delays,orange,Increase in demand---- ---- --------Increase in demand---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- --------Increase in demand---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ----Increase in demand---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ----Increase in demand---- ---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----On manufacturing hold---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----On manufacturing hold---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand-- -- ------ -- -- --Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- --On manufacturing hold-- -- -- -- -- -- -- -- --Manufacturing Delays;Increase in demand-- -- ------ -- -- ----Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- -- ----Manufacturing Delays;Increase in demand-- -- ------ ----Increase in demand-- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- ----Manufacturing Delays;Increase in demand-- -- ---- -- ----Increase in demand-- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- ----Manufacturing Delays;Increase in demand-- -- ---- -- ----Increase in demand-- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- --Manufacturing Delays;Increase in demand-- -- ----Increase in demand-- -- -- -- ----On manufacturing hold-- -- -- ----Manufacturing Delays;Increase in demand--             --             --            ----            Increase in demand--             --             --             --             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            On manufacturing hold--             --             --             --            ----            ----            ----            Manufacturing Delays;Increase in demand                                         --             Increase in demand                                                                     --             --             --             --             --             --             --             --             --             On manufacturing hold                                                       --             --             --             Manufacturing Delays,,,,,,,,,,,,,
Hospira,vecuronium,1,11/21/09,4/22/11,Demand increase; Manufacturing delays,orange,Increase in demand---- ---- --------Increase in demand---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- --------Increase in demand---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ----Increase in demand---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ----Increase in demand---- ---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----On manufacturing hold---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----On manufacturing hold---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand-- -- ------ -- -- --Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- --On manufacturing hold-- -- -- -- -- -- -- -- --Manufacturing Delays;Increase in demand-- -- ------ -- -- ----Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- -- ----Manufacturing Delays;Increase in demand-- -- ------ ----Increase in demand-- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- ----Manufacturing Delays;Increase in demand-- -- ---- -- ----Increase in demand-- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- ----Manufacturing Delays;Increase in demand-- -- ---- -- ----Increase in demand-- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- --Manufacturing Delays;Increase in demand-- -- ----Increase in demand-- -- -- -- ----On manufacturing hold-- -- -- ----Manufacturing Delays;Increase in demand--             --             --            ----            Increase in demand--             --             --             --             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            On manufacturing hold--             --             --             --            ----            ----            ----            Manufacturing Delays;Increase in demand                                         --             Increase in demand                                                                     --             --             --             --             --             --             --             --             --             On manufacturing hold                                                       --             --             --             Manufacturing Delays,,,,,,,,,,,,,
Sun,vecuronium,1,11/21/09,4/22/11,Demand increase; Manufacturing delays,orange,Increase in demand---- ---- --------Increase in demand---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- --------Increase in demand---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ----Increase in demand---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ----Increase in demand---- ---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----On manufacturing hold---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----On manufacturing hold---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand-- -- ------ -- -- --Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- --On manufacturing hold-- -- -- -- -- -- -- -- --Manufacturing Delays;Increase in demand-- -- ------ -- -- ----Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- -- ----Manufacturing Delays;Increase in demand-- -- ------ ----Increase in demand-- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- ----Manufacturing Delays;Increase in demand-- -- ---- -- ----Increase in demand-- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- ----Manufacturing Delays;Increase in demand-- -- ---- -- ----Increase in demand-- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- --Manufacturing Delays;Increase in demand-- -- ----Increase in demand-- -- -- -- ----On manufacturing hold-- -- -- ----Manufacturing Delays;Increase in demand--             --             --            ----            Increase in demand--             --             --             --             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            On manufacturing hold--             --             --             --            ----            ----            ----            Manufacturing Delays;Increase in demand                                         --             Increase in demand                                                                     --             --             --             --             --             --             --             --             --             On manufacturing hold                                                       --             --             --             Manufacturing Delays,,,,,,,,,,,,,
Teva,vecuronium,1,11/21/09,4/22/11,Demand increase; Manufacturing delays,orange,Increase in demand---- ---- --------Increase in demand---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- --------Increase in demand---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ----Increase in demand---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ----Increase in demand---- ---- ---- ---- ---- ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----On manufacturing hold---- ---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand---- ---- ------------ ---- ---- ----Increase in demand---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----On manufacturing hold---- ---- ---- ---- ---- ---- ---- ---- ----Manufacturing Delays;Increase in demand-- -- ------ -- -- --Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- --On manufacturing hold-- -- -- -- -- -- -- -- --Manufacturing Delays;Increase in demand-- -- ------ -- -- ----Increase in demand-- -- -- -- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- -- ----Manufacturing Delays;Increase in demand-- -- ------ ----Increase in demand-- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- ----Manufacturing Delays;Increase in demand-- -- ---- -- ----Increase in demand-- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- ----Manufacturing Delays;Increase in demand-- -- ---- -- ----Increase in demand-- -- -- -- -- -- -- -- -- ----On manufacturing hold-- -- -- -- -- --Manufacturing Delays;Increase in demand-- -- ----Increase in demand-- -- -- -- ----On manufacturing hold-- -- -- ----Manufacturing Delays;Increase in demand--             --             --            ----            Increase in demand--             --             --             --             --            ----            ----            ----            ----            ----            ----            ----            ----            ----            On manufacturing hold--             --             --             --            ----            ----            ----            Manufacturing Delays;Increase in demand                                         --             Increase in demand                                                                     --             --             --             --             --             --             --             --             --             On manufacturing hold                                                       --             --             --             Manufacturing Delays,,,,,,,,,,,,,
Genentech,xeloda,1,3/31/11,4/22/11,Product recall,green,Recall of 13 manufacturing lots of the customary 120 count bottles currently approved for use in the US.  Genentech is working closely with FDA to ensure that US supply of Xeloda 500mg tablets remains  unchanged.,,,,,,,,,,,,,
